References
- JohnstonASmithPEEpilepsy in the elderlyExpert Rev Neurother2010101899191021384700
- StephenLJBrodieMJEpilepsy in elderly peopleLancet20003551441144610791538
- FaughtERichmanJMartinRIncidence and prevalence of epilepsy among older U.S. Medicare beneficiariesNeurology20127844845322262750
- TrinkaEGiorgiLPattenASegiethJSafety and tolerability of zonisamide in elderly patients with epilepsyActa Neurol Scand201312842242823773051
- TrinkaEEpilepsy: comorbidity in the elderlyActa Neurol Scand Suppl2003180333614510818
- BrodieMJElderATKwanPEpilepsy in later lifeLancet Neurol200981019103019800848
- SaetreEPeruccaEIsojärviJGjerstadLLAM 40089 Study GroupAn international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderlyEpilepsia2007481292130217561956
- RowanAJRamsayRECollinsJFVA Cooperative Study 428 GroupNew onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepineNeurology2005641868187315955935
- BrodieMJOverstallPWGiorgiLMulticentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study GroupEpilepsy Res199937818710515178
- WerhahnKJKlimpeSBalkayaSTrinkaEKrämerGThe safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational studySeizure20112030531121257324
- KutluayEMcCagueKD’SouzaJBeydounASafety and tolerability of oxcarbazepine in elderly patients with epilepsyEpilepsy Behav2003417518012697143
- GiorgiLGomezGO’NeillFHammerAERisnerMThe tolerability of lamotrigine in elderly patients with epilepsyDrugs Aging20011862163011587248
- ZaccaraGSpecchioLMLong-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literatureNeuropsychiatr Dis Treat2009524925919557119
- RomigiAIzziFPlacidiFEffects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic studyEpilepsy Behav20132617017423312598
- BrodieMJBen-MenachemEChouetteIGiorgiLZonisamide: its pharmacology, efficacy and safety in clinical trialsActa Neurol Scand Suppl2012194192823106522
- ShahJShellenbergerKCanafaxDZNS: chemistry, biotransformation, and pharmacokineticsLevyRMattsonRMeldrumBAntiepileptic Drugs5th edPhiladelphia (PA)Lippincott Williams and Wilkins2002872884
- Eisai Pharmaceuticals IncZonegran (Prescribing Information)Tea-neck (NJ)Eisai Pharmaceuticals Inc2004
- WroeSJZonisamideSimon ShorvonEPEngelJTreatment of Epilepsy3rd edOxfordWiley-Blackwell20091200
- UedaYDoiTTokumaruJWillmoreLJEffect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizuresBrain Res Mol Brain Res20031161612941455
- OkadaMKanekoSHiranoTEffects of zonisamide on dopaminergic systemEpilepsy Res1995221932058991786
- PetersDHSorkinEMZonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsyDrugs1993457607877686468
- FaughtEAyalaRMontourisGGLeppikIEZonisamide 922 Trial GroupRandomized controlled trial of zonisamide for the treatment of refractory partial-onset seizuresNeurology2001571774177911723262
- MasudaYNoguchiHKarasawaTEvidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effectsArzneimittelforschung1994442672698192690
- ItalianoDPeruccaEClinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an updateClin Pharmacokinet20135262764523640503
- Ragueneau-MajlessiILevyRHBergenDCarbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patientsEpilepsy Res20046211115519127
- Ragueneau-MajlessiILevyRHBrodieMSmithDShahJGrundyJSLack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsyClin Pharmacokinet20054451752315871637
- LevyRHRagueneau-MajlessiIGarnettWRLack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsyJ Clin Pharmacol2004441230123415496640
- LevyRHRagueneau-MajlessiIBrodieMJSmithDFShahJPanWJLack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsyTher Drug Monit20052719319815795651
- SillsGBrodieMPharmacokinetics and drug interactions with zonisamideEpilepsia20074843544117319920
- FramptonJEScottLJZonisamide: a review of its use in the management of partial seizures in epilepsyCNS Drugs20051934736715813651
- WallaceJShellenbergerKGrovesLPharmacokinetics of zonisamide in young and elderly subjects [abstract no.6.049]Epilepsia199839190191
- Eisai LimitedA study to evaluate the safety and tolerability and explore the efficacy of zonisamide as add-on therapy in elderly patients with refractory partial seizures2014 Available from: http://www.clinicaltrials.gov/show/show/NCT1546688. NLM identifier: NCT1546688Accessed November 20, 2014
- RamsayREZonisamide (ZNS, Zonegran (R)): efficacy and safety stratified by patient age, p292. abstracts from the 25th International Epilepsy Congress Lisbon, Portugal October 12–16, 2003Epilepsia2003441223
- HasegawaHZonisamide adjunct therapy for elderly intractable seizure in VA outpatient clinicAmerican Epilepsy Society Annual Meeting2003 Abstract 1.038. Available from: www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2084
- ToschesWTisdellJEpilepsy in the older patient: US experience with long-term zonisamide therapy (p535). 7th European Congress on Epileptology Helsinki, Finland, 2–6 July 2006Epilepsia200647117148
- ArifHBuchsbaumRPierroJComparative effectiveness of 10 antiepileptic drugs in older adults with epilepsyArch Neurol20106740841520385905
- ArifHMendirattaAHirschLManagement of epilepsy in the elderlyShorvonSPeruccaEEngelJJrThe Treatment of EpilepsyHobokenWiley-Blackwell2009203218
- BergeyGInitial treatment of epilepsy: special issues in treating the elderlyNeurology200463S40S4815557550
- WhiteJRWalczakTSMarinoSEBeniakTELeppikIEBirnbaumAKZonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control studyNeurology20107551351820697103
- RomigiACervellinoAMarcianiMGCognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open studyEur J Neurol20081519019518217888
- CavannaAESeriSPsychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbiditiesEpilepsy Behav20132928128424070880
- EskandariDZouDKarimiMStenlöfKGroteLHednerJZonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled studyEur Respir J20144414014924627538
- GaddeKMKoppingMFWagnerHR2ndYonishGMAllisonDBBrayGAZonisamide for weight reduction in obese adults: a 1-year randomized controlled trialArch Intern Med20121721557156423147455
- MohammadianinejadSEAbbasiVSajediSAZonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trialClin Neuropharmacol20113417417721738025
- KarceskiSMorrellMJCarpenterDTreatment of epilepsy in adults: expert opinion, 2005Epilepsy Behav20057Suppl 1S1S64 quiz S65–S6716102515